Your browser doesn't support javascript.
loading
Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma.
Lor, Kevin W; Helmons, Pieter J; Belew, Helen; Lane, James R; Ball, Edward D.
Affiliation
  • Lor KW; Department of Pharmacy, University of California San Diego Medical Center, San Diego, CA 92103-8765, USA. kloricacid@gmail.com
Pharmacotherapy ; 32(7): 596-603, 2012 Jul.
Article in En | MEDLINE | ID: mdl-22760691

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Heterocyclic Compounds / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Pharmacotherapy Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hematopoietic Stem Cell Mobilization / Peripheral Blood Stem Cell Transplantation / Heterocyclic Compounds / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Pharmacotherapy Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States